Boomray

Developer of radionuclide-targeted drugs for diagnosis and treatment of cancer

placeChangping District, Beijing, China calendar_todayFounded 2021 language boomray.com

Innovation

3 patent families — focus: Chemistry & metallurgy; filing pace slowing. Cited 16 times.

YearFilings
20223

Investor mix

4 investors on record; lead investors include Sequoia Capital China.

Investor typeCountShare
Venture capital250%
Private equity125%
Other / undisclosed125%
Coming soon